Belt and Road Summit 2025- Deal-making

10–16 Sept 2025 | China (Hong Kong)

Marco Suen

Founder & CEO

Provectus Therapeutics Limited

Hong Kong, China (Hong Kong)

7 profile visitsProject Owner

SIngle Cell Resolution Drug Screening AI Platform : From Drug Discovery to Personalized Cancer Treatment.

My organisation

我们是Provectus Therapeutics Limited,一家专注于开发创新癌症治疗方案的生物制药公司。我们的使命是利用新颖的科学方法,推动药物的发现和开发,旨在为癌症患者提供更有效的治疗选择。我们致力于通过我们的技术平台,为全球医疗社区带来突破性的解决方案,改善患者生活。通过合作与创新,我们希望与行业内的其他专业人士一起,共同推动医疗进步。
Read more

About me

To revolutionize drug development and deliver truly personalized cancer therapies through cutting-edge technology and rigorous research. I welcome opportunities for partnership and collaboration to accelerate the advancement of targeted therapies.

Social media

Marketplace (1)

  • Project

    Single Cell Drug Screening AI Platform

    Our high-throughput single cell drug testing AI platform accelerate cancer research, drug development, and clinical precision.

    • Yes
    • None
    • Equity
    • Bio-Tech
    • Technology
    • Private Project
    • R&D Cooperation
    • Open for negotiation
    • Professional Services
    • Minority Shareholdings
    • 2,500,001 to 5,000,000 USD
    • 1,000,001 to 2,500,000 USD
    • Feasibility Study Completed
    • Public–private partnership / Concession
    Author

    Marco Suen

    Founder & CEO at Provectus Therapeutics Limited

    Hong Kong, China (Hong Kong)